Mercer Global Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Mercer Global Advisors's HAE Position: Q2 2026 in Review
Mercer Global Advisors increased its Haemonetics (HAE) stake by 22% in Q2 2026, buying an estimated $74.6K and bringing the position to 6,366 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #2337.
Mercer Global Advisors first reported a position in HAE in Q1 2021 and has held it in 15 quarters since. The position peaked at $657K in Q1 2021. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Mercer Global Advisors held 6,366 shares of Haemonetics worth $477K as of Q2 2026.
- Mercer Global Advisors bought 1,162 Haemonetics shares in Q2 2026, an estimated $74.6K.
- Haemonetics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2337 holding.
- Mercer Global Advisors first reported a position in Haemonetics in Q1 2021 and has held it in 15 quarters since.
- Mercer Global Advisors's Haemonetics position peaked at $657K in Q1 2021.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.